Background: Crohn’s disease is an inflammatory bowel disease predominantly seen in young people. However, owing to its bimodal age distribution, it reaches its second peak between the ages of 50–70. The treatment of elderly Crohn’s disease patients (described as over 60 years of age) remains controversial. Very few studies have described the treatment of elderly patients in our country.
Case Report: We present the management of the oldest patient ever identified with Crohn’s disease in our country. In light of recent evidence, the optimal agent for treating fragile patients and those with a history of infections is vedolizumab. However, vedolizumab is not reimbursed as a primary treatment in our country. Therefore, we treated the patient with corticosteroids and azathioprine.
Conclusion: We have determined that the use of corticosteroids for induction of remission and azathioprine for maintenance of remission is safe, on a case-by-case basis, within the framework of conditions in our country.